Mode
Text Size
Log in / Sign up
N/A N=200 Randomized Prevention

An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls

Cervical Cancer

Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Oct 2014
Primary outcome: Primary: The Receipt of the First HPV Vaccination — 51; 56 percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
BNI-brief Negotiated Interview (Behavioral)
Age
Pediatric · 11+ yrs
Sex
Female
Sponsor
Boston Medical Center
Primary completion
Oct 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
The Receipt of the First HPV Vaccination
51; 56
SECONDARY
The Secondary Outcome Will be Maternal Knowledge About HPV Vaccine.
10; 5

Summary

In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV vaccine with parents of Black adolescent girls being less likely to accept and comply with HPV immunization schedules than Whites. The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. The investigator's hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.

Eligibility Criteria

Inclusion Criteria

  • 11-15 HPV vaccine eligible adolescent girls

Exclusion Criteria

  • Prior receipt of the HPV vaccine
  • pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01254669). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search